Dr. Ashkan Abbey Presented at the American Academy of Ophthalmology Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented, taught and served as a panelist at AAO 2025, the American Academy of Ophthalmology’s annual meeting held in Orlando, Florida, October 18-20, 2025. Highlights of
read more
Texas Retina’s Dr. Rene Choi Receives “One to Watch” Award at AAO 2025
“Dr. Rene Choi is an exceptional ophthalmologist, distinguished by his unwavering integrity and outstanding kindness and compassion towards his patients. He combines superb clinical and surgical skills in treating retinal and inflammatory
read more
Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic
read more
Eye Injury Prevention Month: Four Tips to Protect Your Eyes
Thousands of eye accidents happen each day, and according to the American Academy of Ophthalmology (AAO), nearly half of all eye injuries occur in the home. Did you know that wearing protective
read more
Getting to Know Benjamin R. Lin, MD
Board-certified ophthalmologist and retina specialist Benjamin R. Lin, MD, joined Texas Retina in September and cares for patients in our Dallas Main, Dallas North and Plano offices. He came to us from
read more
Frequently Asked Questions About Eye Injections
For many retinal diseases like age-related macular degeneration, diabetic retinopathy, retinal vein occlusion and uveitis, an eye injection (also called an intravitreal injection) is the only way we can deliver potentially sight-saving medication where it is needed
read more
Dr. Abbey Spoke About the VERONA Diabetic Macular Edema Clinical Trial at The Retina Society’s Annual Meeting
On behalf of the VERONA study investigators, Texas Retina’s Ashkan M. Abbey, MD, delivered a presentation titled “VERONA: End-of-Study Results from a Phase 2 Trial of EYP-1901 (vorolanib intravitreal insert) versus Aflibercept
read more
Why We Dilate Your Eyes
Patients often ask why we must dilate their eyes. A dilated retina exam is essential to properly diagnosing and monitoring a number of retina conditions, including diabetic retinopathy, macular degeneration and retinal tears or detachment. Your
read more
September is Sports Eye Safety Month
According to Prevent Blindness, there were 43,379 sports-related eye injuries treated in the United States in 2024, an increase of 33 percent from the previous year. Basketball had the highest rate of
read more
Offices Closed for Labor Day on 9/1/25
All Texas Retina offices will be closed on Monday, September 1, 2025, in observance of Labor Day. We wish everyone a safe and happy holiday weekend!
read more